Literature DB >> 9120159

Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves.

J Juvonen1, A Laurila, T Juvonen, H Aläkarppä, H M Surcel, K Lounatmaa, J Kuusisto, P Saikku.   

Abstract

OBJECTIVES: We sought to study the possible presence of Chlamydia pneumoniae in aortic valve stenosis (AVS).
BACKGROUND: Inflammation and immune mechanisms are considered important for the pathogenesis of nonrheumatic AVS. All chlamydial species are able to cause heart infections, and seroepidemiologic studies have indicated an association between chronic C. pneumoniae infection and coronary artery disease. Furthermore, the organism has been demonstrated in atherosclerotic lesions.
METHODS: Aortic valve specimens with varying degrees of macroscopic disease were obtained from 35 subjects--17 consecutive patients undergoing aortic valve replacement for treatment of nonrheumatic AVS and 18 age-matched subjects at autopsy. The possible presence of C. pneumoniae in aortic valves was studied by immunohistochemical analysis, polymerase chain reaction or transmission electron microscopy, or a combination of these.
RESULTS: Positive immunohistochemical staining with C. pneumoniae specific antibody was found in 9 (53%) of 17 patients with advanced aortic valve disease requiring surgical treatment (group A), 8 (80%) of 10 cadavers with clearly macroscopic aortic valve pathology (group B) and 1 (12%) of 8 grossly normal cadaver control subjects (group C). Statistical significance with regard to the presence of C. pneumoniae was found when combined diseased subjects (groups A and B: total 17 of 27 subjects) were compared with group C (p = 0.018). However, when group A was compared with group C, there was only marginal statistical significance (p = 0.088). Finally, there was a strong statistical significance (p = 0.015) when groups B and C were compared. Chlamydia pneumoniae DNA was also found in three stenotic valves, and in two of the three tested valve specimens chlamydia-like particles were seen by electron microscopy.
CONCLUSIONS: Chlamydia pneumoniae is frequently present in nonrheumatic AVS. Similarly, the high number of C. pneumoniae infections detected in the early lesions of "degenerative" AVS suggest that this pathogen may play an etiologic role in the development of this disease. The validity of this relation requires additional study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120159     DOI: 10.1016/s0735-1097(97)00003-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 2.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

3.  Is Mycoplasma pneumoniae associated with vascular disease?

Authors:  B Maraha; A van Der Zee; A M Bergmans; M Pan; M F Peeters; H F Berg; G J Scheffer; J A Kluytmans
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 4.  Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

Review 5.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 6.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: a necropsy study.

Authors:  J Kuusisto; K Räsänen; T Särkioja; E Alarakkola; V-M Kosma
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 8.  [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].

Authors:  W Stille; R Dittmann
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

9.  Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology?

Authors:  Boulos Maraha; Hans Berg; Marjolein Kerver; Steef Kranendonk; Jaap Hamming; Jan Kluytmans; Marcel Peeters; Anneke van der Zee
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 10.  Is there an infective aetiology to atherosclerosis?

Authors:  S Gupta; A J Camm
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.